For research use only. Not for therapeutic Use.
CRA-2059 TFA（Cat No.:I045053）is a trifluoroacetate salt form of a small-molecule anticancer agent under investigation for its ability to modulate key oncogenic pathways. Though its exact mechanism is not widely disclosed, CRA-2059 is believed to interfere with tumor cell proliferation, survival, or metastatic behavior, making it a candidate for targeted cancer therapy. The TFA salt enhances solubility and stability, facilitating formulation for preclinical research. CRA-2059 TFA is primarily used in experimental oncology studies to evaluate efficacy, pharmacokinetics, and resistance mechanisms.
| Synonyms | [(3R,6R)-6-[4-[[4-(diaminomethylideneamino)phenyl]methylcarbamoyl]piperazine-1-carbonyl]oxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl] 4-[[4-(diaminomethylideneamino)phenyl]methylcarbamoyl]piperazine-1-carboxylate;2,2,2-trifluoroacetic acid |
| Molecular Formula | C36H47F3N12O10 |
| Purity | ≥95% |
| IUPAC Name | [(3R,6R)-6-[4-[[4-(diaminomethylideneamino)phenyl]methylcarbamoyl]piperazine-1-carbonyl]oxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl] 4-[[4-(diaminomethylideneamino)phenyl]methylcarbamoyl]piperazine-1-carboxylate;2,2,2-trifluoroacetic acid |
| InChI | InChI=1S/C34H46N12O8.C2HF3O2/c35-29(36)41-23-5-1-21(2-6-23)17-39-31(47)43-9-13-45(14-10-43)33(49)53-25-19-51-28-26(20-52-27(25)28)54-34(50)46-15-11-44(12-16-46)32(48)40-18-22-3-7-24(8-4-22)42-30(37)38;3-2(4,5)1(6)7/h1-8,25-28H,9-20H2,(H,39,47)(H,40,48)(H4,35,36,41)(H4,37,38,42);(H,6,7)/t25-,26-,27?,28?;/m1./s1 |
| InChIKey | MIIYCICULQBHKP-ZGGWIOQZSA-N |
| SMILES | C1CN(CCN1C(=O)NCC2=CC=C(C=C2)N=C(N)N)C(=O)O[C@@H]3COC4C3OC[C@H]4OC(=O)N5CCN(CC5)C(=O)NCC6=CC=C(C=C6)N=C(N)N.C(=O)(C(F)(F)F)O |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
